Azenta Inc (NAS:AZTA)
$ 51.3 -0.27 (-0.52%) Market Cap: 2.34 Bil Enterprise Value: 1.94 Bil PE Ratio: 0 PB Ratio: 1.32 GF Score: 73/100

Azenta Inc at JPMorgan Healthcare Conference Transcript

Jan 11, 2023 / 11:45PM GMT
Release Date Price: $61.84 (-0.18%)
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

Great. Thank you, everybody. My name is Casey Woodring from the Life Science Tools and Diagnostics team here at JPMorgan. I'm pleased to introduce our next presenting company, Azenta Life Sciences.

Joined with me here on stage is CEO, Steve Schwartz. Azenta is going to give a presentation, followed by a Q&A session. But with that, I'll just give it to Steve.

Stephen S. Schwartz
Azenta, Inc. - CEO, President & Director

Great. Thanks, Casey, and good afternoon, everyone. I just want to start with -- I'm here for the distance. I hope my voice will come along with me, so I apologize. But it's good to see everyone and Casey, we're delighted to be here at the JPMorgan conference. So we really appreciate the invitation and the opportunity to present.

As Casey mentioned, I'm Steve Schwartz. I'm the CEO of Azenta Life Sciences. We've been -- Azenta now is a stand-alone life sciences company for a year. So we just passed our 1-year anniversary as a stand-alone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot